Aethlon Medical Inc
AEMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.68M
Close$
$3.11
45.9% upside
Current Fair Value
45.9% upsideUndervalued by 45.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.68 Million |
|---|---|
| Enterprise Value | $-6,537,192,569.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-85.8 |
| Beta | 1.5 |
| Outstanding Shares | 823,126 |
Return
| Return on Equity | -78.55% |
|---|---|
| Return on Assets | -65.45% |
| Return on Invested Capital | -21.76% |
Valuation & Multiples
| P/E Ratio | -0.16 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -37980.44 |
| Enterprise Value to EBIT | 4.42 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.06 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
February 12, 2026
EPS Estimate
$-2.01
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
June 25, 2026
EPS Estimate
$-2.17
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 8.60%▲ 6.60% |
|---|---|
| Total Invested | $155,016▲ 239.63% |
| Investors Holding | 12▲ 4.00% |
ESG Score
No data
About Aethlon Medical Inc
CEO: Timothy Rodell